{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:25:51Z","timestamp":1794522351489,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA055758"],"award-info":[{"award-number":["K01DA055758"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R34DA055228"],"award-info":[{"award-number":["R34DA055228"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute-care interventions that identify patients with substance use disorders (SUDs), initiate treatment, and link patients to community-based services, have proliferated in recent years. Yet, much is unknown about the specific strategies being used to support continuity of care from emergency department (ED) or inpatient hospital settings to community-based SUD treatment. In this scoping review, we synthesize the existing literature on patient transition interventions, and form an initial typology of reported strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched Pubmed, Embase, CINAHL and PsychINFO for peer-reviewed articles published between 2000 and 2021 that studied interventions linking patients with SUD from ED or inpatient hospital settings to community-based SUD services. Eligible articles measured at least one post-discharge treatment outcome and included a description of the strategy used to promote linkage to community care. Detailed information was extracted on the components of the transition strategies and a thematic coding process was used to categorize strategies into a typology based on shared characteristics. Facilitators and barriers to transitions of care were synthesized using the Consolidated Framework for Implementation Research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty-five articles met inclusion criteria. 62% included ED interventions and 44% inpatient interventions. The majority focused on patients with opioid (71%) or alcohol (31%) use disorder. The transition strategies reported across studies were heterogeneous and often not well described. An initial typology of ten transition strategies, including five pre- and five post-discharge transition strategies is proposed. The most common strategy was scheduling an appointment with a community-based treatment provider prior to discharge. A range of facilitators and barriers were described, which can inform efforts to improve hospital-to-community transitions of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Strategies to support transitions from acute-care to community-based SUD services, although critical for ensuring continuity of care, vary greatly across interventions and are inconsistently measured and described. More research is needed to classify SUD care transition strategies, understand their components, and explore which lead to the best patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-023-00422-w","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T04:02:14Z","timestamp":1698897734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7396-3938","authenticated-orcid":false,"given":"Noa","family":"Krawczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca D.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Grivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Heng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhas","family":"Nagappala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honora","family":"Englander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McNeely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"422_CR1","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts national center for health statistics. 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm"},{"key":"422_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3711","volume":"3","author":"WC Goedel","year":"2020","unstructured":"Goedel WC, Shapiro A, Cerd\u00e1 M, Tsai JW, Hadland SE, Marshall BDL. Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States. JAMA Netw Open. 2020;3: e203711.","journal-title":"JAMA Netw Open"},{"key":"422_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/08897077.2018.1545726","volume":"40","author":"IA Binswanger","year":"2019","unstructured":"Binswanger IA, Carroll NM, Ahmedani BK, Campbell CI, Haller IV, Hechter RC, et al. The association between medical comorbidity and healthcare effectiveness data and information set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders. Subst Abus. 2019;40:292\u2013301.","journal-title":"Subst Abus"},{"key":"422_CR4","volume-title":"Availability of Medications for the treatment of alcohol and opioid use disorder in the USA neurotherapeutics","author":"AJ Abraham","year":"2020","unstructured":"Abraham AJ, Andrews CM, Harris SJ, Friedmann PD. Availability of Medications for the treatment of alcohol and opioid use disorder in the USA neurotherapeutics. Berlin: Springer; 2020."},{"key":"422_CR5","doi-asserted-by":"crossref","unstructured":"N Krawczyk BD Rivera V Jent KM Keyes CM Jones M Cerd\u00e1. Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from, 2010 to 2019\". Int J Drug Policy 2022 , 03786","DOI":"10.1016\/j.drugpo.2022.103786"},{"key":"422_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.039","volume":"204","author":"MR Larochelle","year":"2019","unstructured":"Larochelle MR, Bernstein R, Bernson D, Land T, Stopka TJ, Rose AJ, et al. Touchpoints\u2014opportunities to predict and prevent opioid overdose: a cohort study. Drug Alcohol Depend. 2019;204: 107537.","journal-title":"Drug Alcohol Depend"},{"key":"422_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13722-018-0117-1","volume":"13","author":"K Hawk","year":"2018","unstructured":"Hawk K, D\u2019Onofrio G. Emergency department screening and interventions for substance use disorders. Addict Sci Clin Pract. 2018;13:1\u20136. https:\/\/doi.org\/10.1186\/s13722-018-0117-1.","journal-title":"Addict Sci Clin Pract"},{"key":"422_CR8","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1007\/s11606-022-07618-x","volume":"37","author":"H Englander","year":"2022","unstructured":"Englander H, Jones A, Krawczyk N, Patten A, Roberts T, Korthuis PT, et al. A taxonomy of hospital-based addiction care models: a scoping review and key informant interviews. J Gen Intern Med. 2022;37:2821\u201333.","journal-title":"J Gen Intern Med"},{"key":"422_CR9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.annemergmed.2021.04.023","volume":"78","author":"K Hawk","year":"2021","unstructured":"Hawk K, Hoppe J, Ketcham E, LaPietra A, Moulin A, Nelson L, et al. Consensus recommendations on the treatment of opioid use disorder in the emergency department. Ann Emerg Med. 2021;78:434\u201342.","journal-title":"Ann Emerg Med"},{"key":"422_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-021-02636-9","author":"R Shmuts","year":"2021","unstructured":"Shmuts R, Kay A, Beck M. Guidelines for the assessment and management of addiction in the hospitalized patient with opioid use disorder: a twenty-first century update. Intern Emerg Med. 2021. https:\/\/doi.org\/10.1007\/s11739-021-02636-9.","journal-title":"Intern Emerg Med"},{"key":"422_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.109763","volume":"243","author":"H James","year":"2023","unstructured":"James H, Morgan J, Ti L, Nolan S. Transitions in care between hospital and community settings for individuals with a substance use disorder: a systematic review. Drug Alcohol Depend. 2023;243: 109763.","journal-title":"Drug Alcohol Depend"},{"key":"422_CR12","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1111\/add.12950","volume":"110","author":"JE Glass","year":"2015","unstructured":"Glass JE, Hamilton AM, Powell BJ, Perron BE, Brown RT, Ilgen MA. Specialty substance use disorder services following brief alcohol intervention: a meta-analysis of randomized controlled trials. Addiction. 2015;110:1404\u201315.","journal-title":"Addiction"},{"key":"422_CR13","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","volume":"34","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34:2796\u2013803.","journal-title":"J Gen Intern Med"},{"key":"422_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/OAEM.S267416","volume":"12","author":"SS Cao","year":"2020","unstructured":"Cao SS, Dunham SI, Simpson SA. Prescribing buprenorphine for opioid use disorders in the ed: a review of best practices, barriers, and future directions. Open Access Emerg Med. 2020;12:261\u201374.","journal-title":"Open Access Emerg Med"},{"key":"422_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","volume":"45","author":"AR Williams","year":"2019","unstructured":"Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a cascade of care for responding to the opioid epidemic. Am J Drug Alcohol Abuse. 2019;45:1\u201310.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"422_CR16","doi-asserted-by":"crossref","unstructured":"AR Williams KA Johnson CP Thomas S Reif EM Soc\u00edas BF Henry et al 2022. Opioid use disorder Cascade of care framework design: A roadmap 43 1207 1214","DOI":"10.1080\/08897077.2022.2074604"},{"key":"422_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (prisma-scr): checklist and explanation. Ann Intern Med. 2018;169:467.","journal-title":"Ann Intern Med"},{"key":"422_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108410","volume":"130","author":"RW Sullivan","year":"2021","unstructured":"Sullivan RW, Szczesniak LM, Wojcik SM. Bridge clinic buprenorphine program decreases emergency department visits. J Subst Abuse Treat. 2021;130: 108410.","journal-title":"J Subst Abuse Treat"},{"key":"422_CR19","unstructured":"Popay J, Arai L, Rodgers M, Britten N. Guidance on the conduct of narrative synthesis in systematic reviews: A product from the ESRC methods programme communities in control-big local evaluation view project VOICES (ViOlence: impact on children evidence synthesis) View project. 2006. https:\/\/www.researchgate.net\/publication\/233866356"},{"key":"422_CR20","unstructured":"The Consolidated Framework for Implementation research\u2014technical assistance for users of the CFIR framework. https:\/\/cfirguide.org\/"},{"key":"422_CR21","doi-asserted-by":"publisher","first-page":"899","DOI":"10.7326\/M20-5475","volume":"174","author":"J Gryczynski","year":"2021","unstructured":"Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O\u2019Grady KE, Schwartz RP. Preventing hospital readmission for patients with comorbid substance use disorder. Ann Intern Med. 2021;174:899\u2013909.","journal-title":"Ann Intern Med"},{"key":"422_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/08897077.2020.1809608","volume":"42","author":"SE Wakeman","year":"2021","unstructured":"Wakeman SE, Rigotti NA, Herman GE, Regan S, Chang Y, Snow R, et al. The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial. Subst Abus. 2021;42:646\u201353.","journal-title":"Subst Abus"},{"key":"422_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13181-020-00813-4","volume":"17","author":"GA Beauchamp","year":"2021","unstructured":"Beauchamp GA, Laubach LT, Esposito SB, Yazdanyar A, Roth P, Lauber P, et al. Implementation of a medication for addiction treatment (mat) and linkage program by leveraging community partnerships and medical toxicology expertise. J Med Toxicol. 2021;17:176\u201384. https:\/\/doi.org\/10.1007\/s13181-020-00813-4.","journal-title":"J Med Toxicol"},{"key":"422_CR24","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/08897077.2020.1846664","volume":"42","author":"SE Wakeman","year":"2021","unstructured":"Wakeman SE, Kane M, Powell E, Howard S, Shaw C, Kehoe L, et al. A hospital-wide initiative to redesign substance use disorder care: impact on pharmacotherapy initiation. Subst Abus. 2021;42:767\u201374. https:\/\/doi.org\/10.1080\/08897077.2020.1846664.","journal-title":"Subst Abus"},{"key":"422_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1940-0640-7-20","volume":"7","author":"A Pecoraro","year":"2012","unstructured":"Pecoraro A, Horton T, Ewen E, Becher J, Wright PA, Silverman B, et al. Early data from project engage: a program to identify and transition medically hospitalized patients into addictions treatment. Addict Sci Clin Pract. 2012;7:20.","journal-title":"Addict Sci Clin Pract"},{"key":"422_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108234","volume":"215","author":"KA Byrne","year":"2020","unstructured":"Byrne KA, Roth PJ, Merchant K, Baginski B, Robinson K, Dumas K, et al. Inpatient link to peer recovery coaching: results from a pilot randomized control trial. Drug Alcohol Depend. 2020;215: 108234.","journal-title":"Drug Alcohol Depend"},{"issue":"423","key":"422_CR27","first-page":"7","volume":"42","author":"CH Dahlem","year":"2021","unstructured":"Dahlem CH, Scalera M, Anderson G, Tasker M, Ploutz-Snyder R, McCabe SE, et al. Recovery opioid overdose team (ROOT) pilot program evaluation: a community-wide post-overdose response strategy. Subst Abus. 2021;42(423):7.","journal-title":"Subst Abus."},{"key":"422_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/08897077.2020.1856291","volume":"42","author":"TD Brothers","year":"2021","unstructured":"Brothers TD, Fraser J, MacAdam E, Morgan B, Francheville J, Nidumolu A, et al. Implementation and evaluation of a novel, unofficial, trainee-organized hospital addiction medicine consultation service. Subst Abus. 2021;42:433\u20137.","journal-title":"Subst Abus"},{"key":"422_CR29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ajem.2019.12.038","volume":"38","author":"T Kelly","year":"2020","unstructured":"Kelly T, Hoppe JA, Zuckerman M, Khoshnoud A, Sholl B, Heard K. A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers. Am J Emerg Med. 2020;38:1286\u201390.","journal-title":"Am J Emerg Med"},{"key":"422_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.annemergmed.2019.08.420","volume":"75","author":"FJ Edwards","year":"2020","unstructured":"Edwards FJ, Wicelinski R, Gallagher N, McKinzie A, White R, Domingos A. Treating opioid withdrawal with buprenorphine in a community hospital emergency department: an outreach program. Ann Emerg Med. 2020;75:49\u201356.","journal-title":"Ann Emerg Med"},{"key":"422_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jemermed.2019.03.029","volume":"57","author":"CA Dunkley","year":"2019","unstructured":"Dunkley CA, Carpenter JE, Murray BP, Sizemore E, Wheatley M, Morgan BW, et al. Retrospective review of a novel approach to buprenorphine induction in the emergency department. J Emerg Med. 2019;57:181\u20136.","journal-title":"J Emerg Med"},{"key":"422_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2018.12.017","volume":"196","author":"A-S Schwarz","year":"2019","unstructured":"Schwarz A-S, Nielsen B, S\u00f8gaard J, S\u00f8gaard NA. Making a bridge between general hospital and specialised community-based treatment for alcohol use disorder\u2014a pragmatic randomised controlled trial. Drug Alcohol Depend. 2019;196:51\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"422_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsat.2020.02.007","volume":"112","author":"C Bogan","year":"2020","unstructured":"Bogan C, Jennings L, Haynes L, Barth K, Moreland A, Oros M, et al. Implementation of emergency department\u2013initiated buprenorphine for opioid use disorder in a rural southern state. J Subst Abuse Treat. 2020;112:73\u20138.","journal-title":"J Subst Abuse Treat"},{"key":"422_CR34","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.ajem.2020.03.005","volume":"38","author":"LB Monico","year":"2020","unstructured":"Monico LB, Oros M, Smith S, Mitchell SG, Gryczynski J, Schwartz R. One million screened: Scaling up SBIRT and buprenorphine treatment in hospital emergency departments across Maryland. Am J Emerg Med. 2020;38:1466\u20139.","journal-title":"Am J Emerg Med"},{"key":"422_CR35","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2020.6.46452","author":"KT LeSaint","year":"2020","unstructured":"LeSaint KT, Klapthor B, Wang RC, Geier C. Buprenorphine for opioid use disorder in the emergency department: a retrospective chart review. Western J Emerg Med Integr Emerg Care Popul Health. 2020. https:\/\/doi.org\/10.5811\/westjem.2020.6.46452.","journal-title":"Western J Emerg Med Integr Emerg Care Popul Health"},{"key":"422_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/ADM.0000000000000875","volume":"16","author":"S Regan","year":"2022","unstructured":"Regan S, Howard S, Powell E, Martin A, Dutta S, Hayes BD, et al. Emergency department-initiated buprenorphine and referral to follow-up addiction care a program description. J Addict Med. 2022;16:216.","journal-title":"J Addict Med"},{"key":"422_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ajem.2019.158373","volume":"38","author":"KA Kaucher","year":"2020","unstructured":"Kaucher KA, Caruso EH, Sungar G, Gawenus L, Hurlbut K, Sanchez DC, et al. Evaluation of an emergency department buprenorphine induction and medication-assisted treatment referral program. Am J Emerg Med. 2020;38:300\u20134.","journal-title":"Am J Emerg Med"},{"key":"422_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/00981389.2017.1299073","volume":"56","author":"L Berger","year":"2017","unstructured":"Berger L, Hernandez-Meier J, Hyatt J, Brondino M. Referral to treatment for hospitalized medical patients with an alcohol use disorder: a proof-of-concept brief intervention study. Soc Work Health Care. 2017;56:321\u201334.","journal-title":"Soc Work Health Care"},{"key":"422_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jemermed.2021.04.007","volume":"61","author":"LK Jennings","year":"2021","unstructured":"Jennings LK, Lane S, McCauley J, Moreland A, Hartwell K, Haynes L, et al. Retention in treatment after emergency department-initiated buprenorphine. J Emerg Med. 2021;61:211\u201321.","journal-title":"J Emerg Med"},{"key":"422_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1553-2712.2010.00824.x","volume":"17","author":"G D\u2019Onofrio","year":"2010","unstructured":"D\u2019Onofrio G, Degutis LC. Integrating project ASSERT: a screening, intervention, and referral to treatment program for unhealthy alcohol and drug use into an urban emergency department. Acad Emerg Med. 2010;17:903\u201311.","journal-title":"Acad Emerg Med"},{"key":"422_CR41","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","volume":"34","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34:2796\u2013803.","journal-title":"J Gen Intern Med"},{"key":"422_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/ofid\/ofab285","volume":"8","author":"AM Beieler","year":"2021","unstructured":"Beieler AM, Klein JW, Bhatraju E, Iles-Shih M, Enzian L, Dhanireddy S. Evaluation of bundled interventions for patients with opioid use disorder experiencing homelessness receiving extended antibiotics for severe infection. Open Forum Infect Dis. 2021;8:285.","journal-title":"Open Forum Infect Dis"},{"key":"422_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/09638237.2017.1294733","volume":"29","author":"MJ O\u2019Connell","year":"2020","unstructured":"O\u2019Connell MJ, Flanagan EH, Delphin-Rittmon ME, Davidson L. Enhancing outcomes for persons with co-occurring disorders through skills training and peer recovery support. J Ment Health. 2020;29:6\u201311.","journal-title":"J Ment Health"},{"key":"422_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1300\/J465v25n01_03","volume":"25","author":"S Rochat","year":"2004","unstructured":"Rochat S, Wietlisbach V, Burnand B, Landry U, Yersin B. Success of referral for alcohol dependent patients from a general hospital. Subst Abus. 2004;25:9\u201315. https:\/\/doi.org\/10.1300\/J465v25n01_03.","journal-title":"Subst Abus"},{"key":"422_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jsat.2019.02.005","volume":"100","author":"J Kmiec","year":"2019","unstructured":"Kmiec J, Suffoletto B. Implementations of a text-message intervention to increase linkage from the emergency department to outpatient treatment for substance use disorders. J Subst Abuse Treat. 2019;100:39\u201344.","journal-title":"J Subst Abuse Treat"},{"key":"422_CR46","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1037\/0022-006X.73.6.1026","volume":"73","author":"JL Sorensen","year":"2005","unstructured":"Sorensen JL, Masson CL, Delucchi K, Sporer K, Barnett PG, Mitsuishi F, et al. Randomized trial of drug abuse treatment-linkage strategies. J Consult Clin Psychol. 2005;73:1026\u201335.","journal-title":"J Consult Clin Psychol"},{"key":"422_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108595","volume":"221","author":"DP Watson","year":"2021","unstructured":"Watson DP, Weathers T, McGuire A, Cohen A, Huynh P, Bowes C, et al. Evaluation of an emergency department-based opioid overdose survivor intervention: difference-in-difference analysis of electronic health record data to assess key outcomes. Drug Alcohol Depend. 2021;221: 108595.","journal-title":"Drug Alcohol Depend"},{"key":"422_CR48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s11606-017-3993-2","volume":"32","author":"G D\u2019Onofrio","year":"2017","unstructured":"D\u2019Onofrio G, Chawarski MC, O\u2019Connor PG, Pantalon MV, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: outcomes during and after intervention. J Gen Intern Med. 2017;32:660\u20136.","journal-title":"J Gen Intern Med"},{"key":"422_CR49","first-page":"63","volume":"40","author":"C Roncero","year":"2012","unstructured":"Roncero C, Rodr\u00edguez-Cintas L, Barral C, Fuste G, Daigre C, Ramos-Quiroga J, et al. Treatment adherence to treatment in substance users referred from psychiatric emergency service to outpatient treatment. Actas Esp Psiquiatr. 2012;40:63\u20139.","journal-title":"Actas Esp Psiquiatr"},{"key":"422_CR50","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1017\/cem.2019.24","volume":"21","author":"T Hu","year":"2019","unstructured":"Hu T, Snider-Adler M, Nijmeh L, Pyle A. Buprenorphine\/naloxone induction in a Canadian emergency department with rapid access to community-based addictions providers. CJEM. 2019;21:492\u20138.","journal-title":"CJEM"},{"key":"422_CR51","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.annemergmed.2018.04.007","volume":"72","author":"HC Duber","year":"2018","unstructured":"Duber HC, Barata IA, Cio\u00e8-Pe\u00f1a E, Liang SY, Ketcham E, Macias-Konstantopoulos W, et al. Identification, management, and transition of care for patients with opioid use disorder in the emergency department. Ann Emerg Med. 2018;72:420\u201331.","journal-title":"Ann Emerg Med"},{"key":"422_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108009","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang Y, Nielsen S, Kuhn L, Lam T. A systematic review of opioid overdose interventions delivered within emergency departments. Drug Alcohol Depend. 2020. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108009.","journal-title":"Drug Alcohol Depend"},{"key":"422_CR53","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/jhm.12893","volume":"17","author":"SL Calcaterra","year":"2022","unstructured":"Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, et al. Management of opioid use disorder and associated conditions among hospitalized adults: a consensus statement from the society of hospital medicine. J Hosp Med. 2022;17:744\u201356.","journal-title":"J Hosp Med"},{"key":"422_CR54","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMp1606157","volume":"375","author":"L Fanucchi","year":"2016","unstructured":"Fanucchi L, Lofwall MR. Putting parity into practice\u2014integrating opioid-use disorder treatment into the hospital setting. N Engl J Med. 2016;375:811\u20133.","journal-title":"N Engl J Med"},{"key":"422_CR55","unstructured":"SAMHSA. Use of Medication-Assisted Treatment in Emergency Departments. SAMHSA Publications and Digital Products. 2021. https:\/\/store.samhsa.gov\/product\/use-of-mat-in-emergency-departments\/pep21-pl-guide-5"},{"key":"422_CR56","unstructured":"FACT SHEET: Addressing addiction and the overdose epidemic | The White House [Internet]. https:\/\/www.whitehouse.gov\/briefing-room\/statements-releases\/2022\/03\/01\/fact-sheet-addressing-addiction-and-the-overdose-epidemic\/"},{"key":"422_CR57","doi-asserted-by":"publisher","DOI":"10.1377\/forefront.20230210.535750\/full\/","author":"N Krawczyk","year":"2013","unstructured":"Krawczyk N, Jordan A, Cerd\u00e1 M. Optimizing opioid settlement funds to save lives: investing in equitable solutions. Health Affairs Forefront. 2013. https:\/\/doi.org\/10.1377\/forefront.20230210.535750\/full\/.","journal-title":"Health Affairs Forefront"},{"key":"422_CR58","doi-asserted-by":"publisher","first-page":"625","DOI":"10.12788\/jhm.3455","volume":"15","author":"LJ Faherty","year":"2020","unstructured":"Faherty LJ, Hadland SE, Stein BD, Patrick SW. Multiplying the impact of opioid settlement funds by investing in primary prevention. J Hosp Med. 2020;15:625.","journal-title":"J Hosp Med"},{"key":"422_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.12788\/jhm.2736","volume":"12","author":"H Englander","year":"2017","unstructured":"Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, et al. Planning and designing the improving addiction care team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12:339\u201342.","journal-title":"J Hosp Med"},{"key":"422_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/jhm.2502","volume":"11","author":"D Kansagara","year":"2016","unstructured":"Kansagara D, Chiovaro JC, Kagen D, Jencks S, Rhyne K, O\u2019Neil M, et al. So many options, where do we start? An overview of the care transitions literature. J Hosp Med. 2016;11:221\u201330.","journal-title":"J Hosp Med"},{"key":"422_CR61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/add.13652","volume":"112","author":"J Vendetti","year":"2017","unstructured":"Vendetti J, Gmyrek A, Damon D, Singh M, McRee B, Del Boca F. Screening, brief intervention and referral to treatment (SBIRT): implementation barriers, facilitators and model migration. Addiction. 2017;112:23\u201333.","journal-title":"Addiction"},{"key":"422_CR62","volume":"2","author":"CE Fockele","year":"2021","unstructured":"Fockele CE, Duber HC, Finegood B, Morse SC, Whiteside LK. Improving transitions of care for patients initiated on buprenorphine for opioid use disorder from the emergency departments in King County, Washington. J Am Coll Emerg Phys Open. 2021;2: e12408.","journal-title":"J Am Coll Emerg Phys Open"},{"key":"422_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108411","volume":"130","author":"AB Collins","year":"2021","unstructured":"Collins AB, Beaudoin FL, Samuels EA, Wightman R, Baird J. Facilitators and barriers to post-overdose service delivery in Rhode Island emergency departments: a qualitative evaluation. J Subst Abuse Treat. 2021;130: 108411.","journal-title":"J Subst Abuse Treat"},{"key":"422_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1080\/24734306.2020.1869899","volume":"5","author":"A Upadhyaya","year":"2021","unstructured":"Upadhyaya A, Marks LR, Schwarz ES, Liang SY, Durkin MJ, Liss DB. Care cascade for patients with opioid use disorder and serious injection related infections. Toxicol Commun. 2021;5:6\u201310.","journal-title":"Toxicol Commun"},{"key":"422_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.drugalcdep.2019.07.002","volume":"202","author":"JT Prieto","year":"2019","unstructured":"Prieto JT, McEwen D, Davidson AJ, Al-Tayyib A, Gawenus L, Papagari Sangareddy SR, et al. Monitoring opioid addiction and treatment: Do you know if your population is engaged? Drug Alcohol Depend. 2019;202:56\u201360.","journal-title":"Drug Alcohol Depend"},{"key":"422_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1452326","author":"H Englander","year":"2018","unstructured":"Englander H, Wilson T, Collins D, Phoutrides E, Weimer M, Korthuis PT, et al. Lessons learned from the implementation of a medically enhanced residential treatment (MERT) model integrating intravenous antibiotics and residential addiction treatment. New pub. 2018. https:\/\/doi.org\/10.1080\/08897077.2018.1452326.","journal-title":"New pub"},{"key":"422_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108848","volume":"141","author":"SE Wakeman","year":"2022","unstructured":"Wakeman SE, McGovern S, Kehoe L, Kane MT, Powell EA, Casey SK, et al. Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic. J Subst Abuse Treat. 2022;141: 108848.","journal-title":"J Subst Abuse Treat"},{"key":"422_CR68","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2020.7.46079","author":"A Martin","year":"2022","unstructured":"Martin A, Butler K, Chavez T, Herring A, Wakeman S, Hayes BD, et al. Integrating emergency care with population health title beyond buprenorphine: models of follow-up care for patients with opioid use disorder in the ed publication date license beyond buprenorphine: models of follow-up care for opioid use disorder in the emergeny department. Western J Emerg Med Integr Emerg Care Population Health. 2022. https:\/\/doi.org\/10.5811\/westjem.2020.7.46079.","journal-title":"Western J Emerg Med Integr Emerg Care Population Health"},{"key":"422_CR69","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.annemergmed.2022.05.010","volume":"80","author":"LK Whiteside","year":"2022","unstructured":"Whiteside LK, D\u2019Onofrio G, Fiellin DA, Edelman EJ, Richardson L, O\u2019Connor P, et al. Models for implementing emergency department-initiated buprenorphine with referral for ongoing medication treatment at emergency department discharge in diverse academic centers. Ann Emerg Med. 2022;80:410\u20139.","journal-title":"Ann Emerg Med"},{"key":"422_CR70","doi-asserted-by":"publisher","DOI":"10.1080\/0095299020232169832","author":"Z Lindenfeld","year":"2023","unstructured":"Lindenfeld Z, Franz B, Cronin C, Chang JE. Hospital adoption of harm reduction and risk education strategies to address substance use. Am J Alcohol Abuse. 2023. https:\/\/doi.org\/10.1080\/0095299020232169832.","journal-title":"Am J Alcohol Abuse"},{"key":"422_CR71","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jsat.2016.06.003","volume":"68","author":"PA Cushman","year":"2016","unstructured":"Cushman PA, Liebschutz JM, Anderson BJ, Moreau MR, Stein MD. Buprenorphine initiation and linkage to outpatient buprenorphine do not reduce frequency of injection opiate use following hospitalization. J Subst Abuse Treat. 2016;68:68\u201373. https:\/\/doi.org\/10.1016\/j.jsat.2016.06.003.","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"422_CR72","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1016\/j.ajem.2020.09.007","volume":"38","author":"I Shaw","year":"2020","unstructured":"Shaw I, Faryar KA, Ryan RJ, Ancona RM, Fernandez FJ, Lyons MS. Evaluation of low-intensity initiatives to improve linkage to care for emergency department patients with opioid use disorder. Am J Emerg Med. 2020;38(11):2391\u20134. https:\/\/doi.org\/10.1016\/j.ajem.2020.09.007.","journal-title":"Am J Emerg Med"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00422-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00422-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T04:05:17Z","timestamp":1698897917000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00422-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["422"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00422-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.24.23289042","asserted-by":"object"}]},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Noa Krawczyk receives funds for expert testimony in ongoing opioid litigation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}